GNH USA

Europe — EMA

Minims Tropicamide Bausch + Lomb

GNH USA supplies Minims Tropicamide Bausch + Lomb (Tropicamide), a muscarinic antagonist for inducing mydriasis and cycloplegia during eye examinations.

Request sourcing

1
Pack/s

What is Tropicamide?

Tropicamide, the active ingredient in Minims Tropicamide Bausch + Lomb, is a muscarinic antagonist presented as an eye‑drop formulation for ocular use. It induces pupil dilation and temporary loss of accommodation to aid eye examinations and diagnostic procedures.

GNH USA supplies Minims Tropicamide Bausch + Lomb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent quality across global markets. Our distribution network ensures timely delivery and compliance with local import requirements.

What is Tropicamide used for?

Tropicamide is a muscarinic antagonist used in ophthalmology to achieve pupil dilation and cycloplegia. - Ophthalmic examination: induces mydriasis to allow detailed visualization of intra‑ocular structures. - Diagnostic procedures: provides cycloplegia for accurate refraction and assessment of the lens. - Anterior segment surgery: facilitates pupil dilation needed for certain surgical interventions.

What are the side effects of Tropicamide?

Adverse reactions to tropicamide eye drops are generally mild and transient, but serious events can occur.

Common Side Effects: - Stinging or burning sensation upon instillation. - Transient blurred vision. - Photophobia due to pupil dilation. - Mild increase in intra‑ocular pressure. - Temporary ocular redness. - Mild headache.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma. - Severe allergic reaction, including anaphylaxis. - Persistent mydriasis leading to prolonged photophobia. - Corneal edema. - Systemic anticholinergic effects such as tachycardia or dry mouth.

What precautions apply to Tropicamide?

When prescribing tropicamide, clinicians should consider several safety measures. - Assess intra‑ocular pressure: avoid use in patients with narrow‑angle or uncontrolled glaucoma. - Check for hypersensitivity: discontinue if any allergic reaction occurs. - Avoid use in children unless specifically directed by an eye‑care professional. - Inform patients about temporary visual disturbances such as blurred vision and light sensitivity. - Store at room temperature: keep in the original container, protect from light and moisture.

What does Tropicamide interact with?

Tropicamide may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Other mydriatics: additive effect causing excessive pupil dilation. - Systemic anticholinergic drugs: increased overall anticholinergic load. - Beta‑blocker eye drops: may mask intra‑ocular pressure changes.

Moderate Interactions (Monitor Closely): - Topical anesthetics: may enhance ocular irritation. - Systemic antihistamines: may increase photophobia. - Certain anti‑inflammatory eye drops: monitor for altered efficacy.

Frequently asked questions

What is Minims Tropicamide Bausch + Lomb used for?+
Minims Tropicamide Bausch + Lomb is an ophthalmic eye drop used to dilate the pupil (mydriasis) and temporarily paralyze accommodation (cycloplegia). This facilitates comprehensive eye examinations, diagnostic testing, and certain surgical procedures by providing a clear view of intra‑ocular structures.
How does tropicamide work?+
Tropicamide works by competitively blocking muscarinic acetylcholine receptors in the iris sphincter muscle. By preventing parasympathetic stimulation, the sphincter relaxes, leading to pupil dilation and loss of the eye’s focusing ability, which are useful for diagnostic and therapeutic purposes.
What is the usual dose of Minims Tropicamide Bausch + Lomb?+
The dosing regimen is determined by the prescribing eye‑care professional. Typically, one to two drops are instilled in the affected eye(s) as directed, with the interval and any repeat dosing specified by the clinician based on the required degree of dilation.
Is Minims Tropicamide Bausch + Lomb safe in pregnancy or breastfeeding?+
Safety data for tropicamide during pregnancy and lactation are limited, and it is generally classified as a category C or unknown drug. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, after consultation with a qualified healthcare provider.
How do I order Minims Tropicamide Bausch + Lomb from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does tropicamide compare with other mydriatic agents?+
Tropicamide has a relatively rapid onset and short duration of action compared with agents such as phenylephrine or cyclopentolate. It provides sufficient pupil dilation for routine examinations while minimizing prolonged visual disturbance, making it a preferred choice for many diagnostic settings.
What are the storage and handling requirements for Minims Tropicamide Bausch + Lomb?+
Store at room temperature, ideally below 25 °C, in the original sealed container. Protect the bottle from direct light and moisture, and keep it out of reach of children. Do not freeze the solution.
How is Minims Tropicamide Bausch + Lomb administered?+
The product is supplied as a sterile ophthalmic solution. The patient or clinician instills the prescribed number of drops into the conjunctival sac of the target eye(s) using the provided dropper, avoiding contact with the eye or surrounding tissues, and follows any post‑administration instructions.
What are the most serious risks associated with tropicamide eye drops?+
Although uncommon, serious adverse events include acute angle‑closure glaucoma, severe allergic reactions such as anaphylaxis, and prolonged mydriasis leading to significant photophobia. Patients should seek immediate medical attention if they experience severe eye pain, sudden vision loss, or systemic allergic symptoms.
Who should not use Minims Tropicamide Bausch + Lomb?+
Contraindications include individuals with known hypersensitivity to tropicamide or any formulation component, patients with narrow‑angle or uncontrolled glaucoma, and anyone in whom pupil dilation could compromise ocular health. Use should be avoided unless a qualified eye‑care professional determines it is safe.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Tropicamide
Route
Ocular Use
Manufacturer
Bausch + Lomb Ireland Limited
Origin
EU

Related products